Showing results (1981-1990 of 2,391) with videos related to
Sort By:
Pageof 240
Digestive Diseases (Basel, Switzerland)|August 23, 2016
Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?Patrizia Kump, Christoph HögenauerDigestive Diseases (Basel, Switzerland)|July 7, 2017
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal DisordersLoris Riccardo Lopetuso, Valentina Petito, Cristina Graziani, et al.Digestive Diseases (Basel, Switzerland)|April 23, 2018
Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 DiabetesAlia Hadefi, Vincent Huberty, Arnaud Lemmers, et al.Digestive Diseases (Basel, Switzerland)|July 5, 2017
Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with SorafenibChristian Labenz, Vera Prenosil, Sandra Koch, et al.Digestive Diseases (Basel, Switzerland)|May 17, 2019
Age Affects Clinical Management after Noncurative Endoscopic Submucosal Dissection for Early Gastric CancerMitsuru Esaki, Waku Hatta, Tooru Shimosegawa, et al.Digestive Diseases (Basel, Switzerland)|May 17, 2019
Benefit of Pelvic Floor Physical Therapy in Pediatric Patients with Dyssynergic Defecation ConstipationClaire Zar-Kessler, Braden Kuo, Elizabeth Cole, et al.Digestive Diseases (Basel, Switzerland)|May 9, 2019
The Diagnosis and Therapy of Helicobacter pylori Infection in Hungary: Comparison of Strategies Applied by Family Physicians and InternistsBernadett Márkus, László Herszényi, Melinda Matyasovszky, et al.Digestive Diseases (Basel, Switzerland)|May 9, 2019
Portal Angiogenesis in Chronic Liver Disease Patients Correlates with Portal Pressure and Collateral FormationCarolina A Serrano, Simon C Ling, Sofia Verdaguer, et al.Digestive Diseases (Basel, Switzerland)|November 5, 1999
Hypersensitivity and hyperreactivity in the irritable bowel syndrome: An opportunity for drug discoveryG J SangerDigestive Diseases (Basel, Switzerland)|March 24, 2000
Empirical trials in treatment of gastroesophageal reflux diseaseR FassPageof 240